1) Wang MC, Valenzuela LA, Murphy GP, et al:Purification of a human prostate specific antigen. Invest Urol 17:159-163, 1979
2) Catalona WJ, Hudson MA, Scardino PT, et al:Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer:receiver operating characteristics curves. J Urol 152:2037-2042, 1994
3) Hara M, Koyanagi Y, Inoue T, et al:Some physico-chemical characteristics of "gamma-seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fruids and secretion. Ⅶ. Nihon Hoigaku Zasshi 25:322-324, 1971
4) Catalona WJ, Partin AW, Slawin KM, et al:Use of the percentage of free prostate-specific antigen to enhance differenciation of prostate cancer from benign prostatic disease. JAMA 279:1542-1547, 1998
5) Djavan B, Zlotta AR, Byttebier G, et al:Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol 160:411-419, 1998
6) Ito K, Yamamoto T, Kubota Y, et al:Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer. Urology 56:278-282, 2000
7) Carter HB, Pearson JD, Metter EJ, et al:Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267:2215-2220, 1992
8) Garzotto M, Hudson RG, Peters L, et al:Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parametersin patients with prostate specific antigen<10ng/ml. Cancer 98:1417-1422, 2003
9) Suzuki H, Komiya A, Kamiya N, et al:Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology 67:131-136, 2006
10) Kawamura K, Suzuki H, Kamiya N, et al:Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10ng/ml. Int J Urol 15:598-603, 2008